Member Directory

Profile

xenotoxit_306061's picture

Ilya B. Tsyrlov, M.D., Ph.D., D.Sci. (Biochemistry)

XENOTOX, Inc.

Contact Information

Ilya B. Tsyrlov, M.D., Ph.D., D.Sci. (Biochemistry)
Scarsdale, United States

Professional Information

Founder/President
XENOTOX, Inc.
http://www.xenobiovir.com/

Education

M.D. degree (with distinction) in Internal Medicine, 1970, Diploma No. P467542, 1964-1970, University Medical School, Novosibirsk, Russian Federation Ph.D. degree (Biochemistry),1973, Diploma No. MBL-01811, Postgraduate University Researcher's Ph.D. Course (Ph.D. Thesis: Drug-Metabolizing Enzyme Systems of Normal and Cirrhotic Liver) Senior Research Scientist degree (Biochemistry), 1980, Certificate of Russian Government Commission for Science (RGCS), Diploma # CH 18029 D.Sci. degree (Doctor of Biological Sciences in Biochemistry), 1983 (D.Sci. Thesis: “Induction of Membrane-Bound Drug-Metabolizing Monooxygenases”). RGCS Certificate # BL 001240 Postdoctoral training/Professorships: Fellowship in Molecular Biology (1973-1974), IOC & ICEM RAS, Novosibirsk Institute of Molecular Biology, National Academy of Sciences, 1981-83, Prague, Czech Republic University of Surrey, 1989, Guildford, UK Institute of Pharmaceutical Chemistry, University of Frankfurt/Main, 1989, Germany Merck Sharp & Dohme Research Laboratories, 1990, Rahway, NJ EPA, Environmental Toxicology Division (MD-66), 1992, 2006, Research Triangle Park, NC Supervision of Postgraduate and Postdoctoral Students: 23 Ph.D. students and postdoctoral fellows in Russia (17) and in the United States (6) Editorial Boards/Reviewer Work for Journals: Biochemistry (Russia), Bulletin of Experimental Biology and Medicine (Russia), Archives of Biochemistry and Biophysics, Cancer Research, Journal of Pharmacology and Experimental Therapeutics, European Journal of Drug Metabolism & Pharmacokinetics, Carcinogenesis, Hepatology, Journal of Hepatology, Toxicology & Applied Pharmacology. Special Appointments: The finalist candidate elected by the Governing Council, WHO, for the post of Director of the International Agency for Research on Cancer (IARC), 1993; Member, Organizing Committee, International Symposium on Dioxin and Related Compounds (1990, 1996, 2002, 2009); Regional Editor, ISSX Newsletter (1981-1990, 2004-2018); Session Chairman: ESBP Symposium, 1988; DIOXIN Meetings, 2006, 2014; IMMDM Congress, 1994, 2002; Keystone symposia, 2010. Invited Lectures: U. of Turku, 1978, Finland. Comenius U., 1980, 1985, Bratislava, Slovakia. Charles U., 1980, Prague, Czech Republic. U. of Kuopio, 1982, Finland. Centre de Medicament, 1984, Nancy, France. U. of Konstanz, 1988, Germany. U. of Medicine & Dentistry of NJ, 1989,1996, NJ. National Cancer Institute, NIH, 1989-1991, MD. U. of Nebraska Medical Center, 1989, Omaha. St. Mary's Hospital Med School, 1989, London, UK. Chelsea College, University of London, 1989, UK. U. ICRF, 1989, Edinburgh, Scotland. U. of Tübingen, 1989, Germany. U. of Connecticut, 1990, 2008, Farmington, CT. U. of Maryland at Baltimore, 1990, MD. U. of Texas, 1990, 1999, Dallas, TX. Texas A & M U., 1990, College Station, TX. State Lab Hazard Compounds, 1990, Berkeley, CA. State U. of North Carolina, 1992, Raleigh. Cornell U., 1992, Ithaca, NY. U. of Yokohama, 1994, Japan. EPA, Research Triangle Park, NC, 1992, 2006. Dartmouth Medical School, 1993, 1997, Hanover, NH. U. of Toronto, 1995, 2009, Canada. NIOSH/CDC, 1996, Morgantown, WV. Weizmann Institute, 2000, 2005, Rehovot, Israel. Oslo U., 2006, Norway. Novosibirsk U., 1994, 2005, 2006, Russia. U. of Saigon,1989 & U. of Hanoi, 2006, Vietnam. U. of Tokyo, 2007, 2018, Japan. U. of Vienna, 2007, 2013, 2018, Austria. University of Birmingham, 2008, 2016, UK. U. of Kuala Lumpur, 2008, 2021, Malaysia. U. of Kyoto, 2010, 2015 Japan. U. of Hong Kong, 2011, Hong Kong. U. of Dubrovnik, 2012, Croatia. U. of Madrid, 2014, Spain. Free U. of Berlin, 2016, Germany. U. of Milan, 2017, Italy. U. of Amsterdam, 2018, Netherlands. U. of Basel, 2021 and U. of Zurich, 2022, Switzerland.